Earnings calendar/CORZ
Core Scientific, Inc./tx (CORZ)
Core Scientific, Inc./tx (CORZ) Q3 FY2026 (quarter ended ), 10-Q filed (accession 0001839341-26-000030): revenue $232.9M, net income $1.2B, diluted EPS $0.47. Trailing four filed quarters ( to ): revenue $592.1M, diluted EPS -$5.54. Figures from the SEC filing, in USD, as reported.
Quarter-by-quarter results read from the company's own filed statements — period end, filing date, diluted EPS, revenue and year-over-year change. Consensus estimates are shown only where one exists.
Latest filed quarter
The most recent quarter Core Scientific, Inc./tx has filed, from EvidInvest's standardized statements.
Period end
Sep 30, 2026
Q3 FY2026
EPS (diluted)
$0.47
Est. $-0.05 · +1130.7%
Revenue
$232.9M
Est. $196.5M · +18.5%
Net income
$1.18B
As filed
EPS YoY
+204.4%
vs quarter ended 2025-09-30
Revenue YoY
+187.1%
vs quarter ended 2025-09-30
Next report
Mar 1, 2027
Third-party calendar date, not confirmed by a company filing · est. EPS $0.01
Run-rate
Trailing twelve months, summed from the last four filed quarters.
TTM EPS (diluted)
$-5.54
2025-12-31 through 2026-09-30
TTM revenue
$592.1M
2025-12-31 through 2026-09-30
Filed quarters
23
On record here
EPS at or above estimate (4Q)
25%
Of the last four quarters that carry an estimate
Filed quarters
One row per filed statement, newest first
| Period end | Filed | EPS diluted | Revenue | EPS YoY | Revenue YoY | Est. EPS | Surprise |
|---|---|---|---|---|---|---|---|
| 2026-09-30Q3 FY2026 | 2026-11-05 | $0.47 | $232.9M | +204.4% | +187.1% | $-0.05 | +1130.7% |
| 2026-06-30Q2 FY2026 | 2026-07-28 | $-3.32 | $164.2M | -8200.0% | +108.8% | $-0.06 | -5203.5% |
| 2026-03-31Q1 FY2026 | 2026-05-06 | $-1.06 | $115.2M | -185.5% | +44.9% | $-0.02 | -5200.0% |
| 2025-12-31Q4 FY2025 | 2026-03-02 | $-1.63 | $79.8M | -136.2% | -16.0% | $-0.27 | -503.7% |
| 2025-09-30Q3 FY2025 | 2025-10-24 | $-0.45 | $81.1M | +61.5% | -14.9% | $-0.07 | -544.7% |
| 2025-06-30Q2 FY2025 | 2025-08-08 | $-0.04 | $78.6M | +99.2% | -44.3% | $-0.07 | +42.9% |
| 2025-03-31Q1 FY2025 | 2025-05-07 | $1.24 | $79.5M | +59.0% | -55.6% | $-0.12 | +1133.3% |
| 2024-12-31Q4 FY2024 | 2026-03-02 | $-0.69 | $94.9M | -32.7% | -33.1% | $-0.06 | -1050.0% |
| 2024-09-30Q3 FY2024 | 2024-11-06 | $-1.17 | $95.4M | -963.6% | -15.5% | $-0.11 | -963.6% |
| 2024-06-30Q2 FY2024 | 2024-08-07 | $-5.05 | $141.1M | -25150.0% | +11.2% | $0.01 | -59511.8% |
| 2024-03-31Q1 FY2024 | 2024-05-09 | $0.78 | $179.3M | — | +48.6% | $0.13 | +500.0% |
| 2023-12-31Q4 FY2023 | 2024-03-13 | $-0.52 | $141.9M | +50.9% | +17.1% | $-0.03 | -1633.3% |
| 2023-09-30Q3 FY2023 | 2023-11-06 | $-0.11 | $112.9M | +91.1% | -30.6% | — | — |
| 2023-06-30Q2 FY2023 | 2023-08-04 | $-0.02 | $126.9M | +99.2% | -22.6% | — | — |
| 2023-03-31Q1 FY2023 | 2023-05-15 | $0.00 | $120.7M | +100.0% | -37.3% | — | — |
| 2022-12-31Q4 FY2022 | 2023-04-04 | $-1.06 | $121.3M | -524.0% | -59.8% | — | — |
| 2022-09-30Q3 FY2022 | 2022-11-22 | $-1.23 | $162.6M | -1657.1% | +43.7% | — | — |
| 2022-06-30Q2 FY2022 | 2022-08-22 | $-2.49 | $164.0M | -12350.0% | +117.7% | — | — |
| 2022-03-31Q1 FY2022 | 2022-05-13 | $-1.52 | $192.5M | -3900.0% | +254.9% | — | — |
| 2021-12-31Q4 FY2021 | 2022-03-30 | $0.25 | $301.8M | — | — | — | — |
| 2021-09-30Q3 FY2021 | 2021-11-15 | $-0.07 | $113.1M | — | — | — | — |
| 2021-06-30Q2 FY2021 | 2021-08-23 | $-0.02 | $75.3M | — | — | — | — |
| 2021-03-31Q1 FY2021 | 2021-05-25 | $0.04 | $54.2M | — | — | — | — |
Need CORZ data in your own agent or pipeline?
The earnings data on this page — report dates, filed EPS/revenue actuals and run-rate history — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.
More on Core Scientific, Inc./tx
Compare with peers
- PTACW · Patriot Acquisition Corp./CI
- USMX · Corgi U.S. Mid-Cap 2x Daily ETF
- USSX · Corgi U.S. Small-Cap 2x Daily ETF
- VSMPX · Vanguard Morningstar Total Stock Market Index Fund Institutional Plus Shares
- VTSAX · Vanguard Total Stock Market Index Fund Admiral Shares
- VITSX · Vanguard Total Stock Market Index Fund Institutional Shares